Melamine contamination in nutritional supplements--Is it an alarm bell for the general consumer, athletes, and 'Weekend Warriors'? by Gabriels, Gary et al.
Gabriels, Gary; Lambert, Mike; Smith, Pete; Wiesner, Lubbe; Hiss,
Donavon (2015) Melamine contamination in nutritional supplements–
Is it an alarm bell for the general consumer, athletes, and ’Weekend
Warriors’? Nutrition journal, 14 (1). 69-. ISSN 1475-2891 DOI:
https://doi.org/10.1186/s12937-015-0055-7
Downloaded from: http://researchonline.lshtm.ac.uk/4651881/
DOI: 10.1186/s12937-015-0055-7
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
RESEARCH Open Access
Melamine contamination in nutritional
supplements - Is it an alarm bell for the general
consumer, athletes, and ‘Weekend Warriors’?
Gary Gabriels1*, Mike Lambert2, Pete Smith1, Lubbe Wiesner1 and Donavon Hiss3
Abstract
Background: Nutritional supplements are used or experimented with by consumers, notably these are; competitive
and recreational athletes of all ages, and ‘weekend warriors’. As a consequence the supplement industry has grown
to meet the increasing demand. A Global Industry Analysts Inc. report indicates that the herbal supplement market
has not declined during the worldwide recession, but in fact exhibited steady growth over the period 2008 to 2009.
It is anticipated that the market will reach US$93.15 billion by the year 2015. These supplements may contain adulterated
substances that may potentially have harmful short - and long-term health consequences to the consumer. “Scrap
Melamine” is such an example, which has been implicated in the kidney failure and death of several cats, dogs and
pigs. In China in 2008, reports described very severe health effects in infants and young children. At the time over 294
000 infants were screened and diagnosed with urinary tract stones and sand-like calculi associated with melamine in
milk products, of which 50 000 infants were hospitalised, and at least six associated deaths, recorded. The extent that
melamine contamination occurs in nutritional supplements is not known. Therefore, the aim of this study was to
determine whether commercially available nutritional and traditional supplement products contain melamine, even
though they are not declared by the manufacturer on the product label.
Methods: A total of 138 nutritional supplements products were obtained from (i) direct purchases from shops,
pharmacies and outlets, (ii) directly from consumers, and (iii) from suppliers, manufacturers and distributors. The
products were laboratory analysed for melamine, using Tandem Liquid Chromatography Mass Spectrometry.
Results: Forty-seven % of all the products (n = 138) tested positive for melamine. Eight-two % of the South African
produced products (n = 27) tested positive and 58 % of the products imported into South Africa (n = 50) tested positive.
The median concentration estimate for melamine in the products tested were, 6.0 μg/g for the 138 supplements tested,
8.9 μg/g for South African produced products, and 6.9 μg/g for products imported into South Africa.
Conclusion: The melamine (undeclared on product label) levels detected in the nutritional supplements products
investigated were within the Tolerable Daily intake (TDI) limit guidelines of 200 μg/g as set by WHO and others.
Melamine over exposure within the context of the nutritional supplements consumption in the products investigated
should not be of concern to the consumer provided the recommended guidelines of daily product use are adhered to.
Further investigation is warranted to determine, (i) the link of melamine as (part) substitute for the perceived total
declared protein content on the product label, (ii) cyanuric and uric acid presence in the supplement products that
could form chemical-complex formation with melamine and/or analogues that could cause adverse health effects.
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Background
Nutritional supplements are used in particular by com-
petitive and recreational athletes of all ages, and ‘week-
end warriors’. The situation is further exacerbated by the
general pressure placed on certain groups to use supple-
ments. For example, young sports participants who are
engaged in developmental and competitive phases of
sport, encounter peer pressure to use supplements. As a
consequence the supplement industry has grown to
meet the increasing demands. A Global Industry Ana-
lysts Inc. report indicates that the supplement market
has not declined during the worldwide recession, but in
fact exhibited steady growth over the period 2008 to
2009. It is anticipated that the market will reach US
$93.15 billion by the year 2015. These supplements may
contain adulterated substances that may potentially have
harmful short - and long-term health consequences to
the consumer [1]. Also, insufficiencies in regulation
of the supplement industry increase the risk of the
nutritional supplements being contaminated. “Scrap
Melamine” is an example of a food additive/adulterant
contaminant. This is composed of multi-amine and
has been used as a source of non-protein nitrogen,
which falsely increases the claimed protein content
[2–4]. Other sources and entry to humans have been
via melamine resin migration to food [5], carry over
from the illegal use of melamine in animal feed or feed
ingredients, and then from feed to products of animal
origin [5].
A variety of effects mentioned or associated with mela-
mine intake, although inconclusive in humans, are,
nephrolithiasis, chronic kidney inflammation, and blad-
der carcinoma [6–9]. As such, melamine has been impli-
cated in the kidney failure and or disease, and deaths of
several cats, dogs and pigs and the healthfulness of ani-
mals due to long-term exposure of maximum melamine
baseline and adulteration levels [2, 10, 11]. Humans have
a risk to urolithiasis formation following long-term ex-
posure to low levels of melamine [12]. The pathogenic
mechanism emanating via oxidative stress from increase
free radical production that cause inflammation [6].
Furthermore, it is speculated from studies in rats that
renal failure occurs as result of crystallization of ‘melamine’
in the kidney, leading to tubular cell necrosis, regeneration,
and expansion [4, 7]. The mechanism of melamine-related
urinary stones formation is still unclear [9].
Melamine also causes sperm cell abnormality, without
any observed evidence of genotoxicity in prokaryotic
or eukaryotic cells [2]. In humans toxicity has been re-
ported although more specificity dose-dependent repro-
ductive toxicity needs to be documented [2]. Melamine
is excreted predominantly in the urine and hence essen-
tially not metabolized in the human body although there
are detectable amounts of melamine in tissue such as
liver, spleen, bladder and brain [2, 8]. Developing organs
in fetus in utero and neonates ex utero are highly sus-
ceptible to the melamine accumulation [8].
The China Melamine Crisis of 2008 reports described
very severe health effects in infants and young children
due to adulterated infant formula with melamine. At the
time, over 294 000 infants were screened and diagnosed
with uncommon in children, urinary tract stones and
sand-like calculi associated with melamine in milk prod-
ucts, of which 50 000 infants were hospitalized, and at
least six associated deaths, recorded [8, 13]. This situ-
ation may have been compounded due to the frequent
intake of baby formula in early infancy, and may not
provide enough time for the total clearance of the mela-
mine between meals, causing gradual accumulation of
the contaminant inside the body [8].
Whilst the infant formula melamine scandal has since
subsided, there is evidence that melamine is ubiquitously
present in the environment and the majority of the gen-
eral population, including children, are most likely still
exposed [14]. Due to the urgent response needed in the
face of the melamine crisis, analytical methodology able
to accurately determine this compound at trace levels
became a requirement to identify potential health
risks involved with consumption of contaminated foods
consumed by humans [15]. Therefore the aim of this
study was to determine whether commercially available
nutritional and traditional supplement products contain
melamine (1,3,5-triazine-2,4,6-triamine), even though
the manufacturer does not declare them on the product
label. A secondary aim was to compare the content to
the Tolerable Daily Intake (TDI) of melamine.
Methods
The nutritional supplements products assessed (n = 138)
were obtained from (i) direct purchases from shops,
pharmacies and outlets, (ii) directly from consumers,
and (iii) from suppliers, manufacturers and distributors.
The produced and purchased in South Africa products,
where based on a combination of, (i) popular nutritional
supplements brands acquired by a questionnaire survey
from elite athletes, (ii) popular product sales as deter-
mined by information as acquired by shops, pharmacies
and outlets which sold nutritional supplements, and (iii)
budget constraints for the research project.
The nutritional supplement formulation types con-
sisted of powder (P) 39 % (54), tablet ground to powder
(P/T) 30 % (42), powder in capsule (P/C) 22 % (30), liquid
in capsule (L/C) 6 % (8), liquid (L) 3 % (4). The products
were laboratory analysed for melamine using Tandem
Liquid Chromatography Mass Spectrometry. This la-
boratory technique was selected because it offers the
desired multiple chemical compound (drug) separation,
selectivity, and sensitivity with appropriate detection
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capability. The approach was to optimize (via infusion)
the analytical instrumentation to detect on the Applied
Biosystems Sciex API 3200 mass spectrometer for mela-
mine. The chromatography method utilized prior to MS/
MS detection was performed using an Agilent 1200 series
HPLC with a Phenomenex Gemini C18 NX (5 μm, 110A,
50 x 2 mm) analytical column. The mobile phase
consisted of acetonitrile: 0.1 % formic acid (1:1, v/v) and
was delivered at a constant flow rate of 0.5 ml/min. The
column was kept in a column compartment at 35 °C. The
retention time for melamine was 0.26 minutes. For the
analysis for melamine the transition from 127.1 to 68.1
atomic mass units was used. Calibration curve was estab-
lished using prepared serial dilution to establish concen-
trations starting from 1000 ng/ml to 1.953 ng/ml (n = 3).
For the assessment screen the Lower Limit of Quantifica-
tion was 1.95 ng/ml (19 ng/g). The quadratic regression
y = −0.00424X2 + 18.3X + 256 with correlation coefficient
of 0.99 was used to estimate qualitative the concentration
of melamine in the nutritional supplement products
investigated.
Results
Of the overall products acquired 47 % tested positive
for melamine. The summarized data (Table 1) shows
that a greater percentage of products (82 %) produced
and purchased in South Africa, compared to those nu-
tritional supplements products (58 %) imported and
purchased in South Africa were contaminated with
melamine. Based on median concentration values the sup-
plement produced and purchased in South Africa had a
higher level of melamine contamination (8860 ng/g) com-
pared to those imported and purchased in South Africa
(6940 ng/g).
Table 2 shows that of overall samples investigated, 38 %
of products that had melamine contamination were powder
products. Powder products (48 %) that were contaminated
with melamine were highest in imported products pur-
chased in South Africa. Products produced and purchased
in South Africa having melamine contamination were high-
est (41 %) in tablet formulation.
Table 3 sets out the daily tolerable daily intake (TDI)
for melamine as stipulated by respective agencies. TDI
refers to the daily amount of a chemical that has been
assessed safe for human being on long-term basis (usu-
ally whole lifetime).Table 4 presents global examples of
melamine contamination in selected products [16].
Based on average weight of a South African being 65.7 kg,
http://en.wikipedia.org/wiki/Body_weight (accessed on the
22nd October 2014), Table 5 provides and illustrative ex-
ample of the required amount to achieve the TDI limit as
presented in Table 3.
Table 6 provides a synopsis for the melamine ‘posi-
tives’ products that were produced and purchased, or
imported and purchased, in South Africa that were in-
vestigated for container label information, in the respective
predetermine categories of potential dangers and warnings,
scientific indication, disclaimers and claims (Some products
provided information in multiple categories).
Discussion
The study shows (Table 1) that of the overall samples ac-
quired in South Africa (n = 138), 64 (47 %) products
tested ‘positive’ for melamine as contaminant. For those
products purchased and produced in South Africa the
number of ‘positives’ for melamine (n = 27) was 22 (82 %),
and imported products and purchased in South Africa
(n = 50) 29 (58 %). None of the products identified as
melamine ‘positive’ had information on the label stating
that melamine may be present as contaminant. This mis-
leading advertising may cause consequence for the health
of the consumers due to chemical risk if non-approved
ingredients are used or contamination occurs as pointed
out by Venter et al. and Meltzer et al. [17, 18], and
melamine adulteration used as ‘protein essence’, to falsely
increase the protein content in products [5].
Many studies have been done in ‘animals’ and scien-
tific assessment to directly link the state of disease
(various stage of disease) to melamine contamination
[6, 11, 19, 20]. The theory is that melamine forms the
central nidus of the stone in the presence of acidified
urine, causing hyperuraturia that may precipitate the
acute urate nephropathy [9]. The morphology of the
Table 1 Summary of Nutritional Supplement products investigated for Melamine
Overall samples acquired
in South Africa
Produced and purchased
in South Africa
Imported and purchased
in South Africa
(n = 138) (n = 27) (n = 50)
Qualitative Assessment Screen Total No. 64 22 29
Positives (%) 47 82 58
Estimate Concentration (*) ≥ LLOQ (ng/g) Low 218 513 218
≥ LLOQ (ng/g) High 127030 127030 76419
Median (ng/g) 6031 8860 6940
* 1ppm = 1mg/kg = 1000ng/g = 1 μg/g
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crystal suggests it may be a composite crystal in humans
[7, 10, 13, 19]. From work done by Rai et al. [2] it is also
known that melamine is not metabolized and has a very
short half-life (approximately 3 h) in the plasma, and
remains predominantly unchanged in urine. Melamine’s
presence in the urine may therefore be an indicator of
consumption of adulterated ‘food’ [2], hence several
international agencies are working together on strategies
to monitor and control melamine contamination [11].
Another source of adulteration could be via pesticide
residues such as cryomazine in products that culminate
in melamine as chemical product.
This finding of low level of melamine in products
can be interpreted as indicating that there should be no
concern for potential adverse health events, based on
melamine content only and the TDI. However other co-
determinants, co-contaminants [8] such as uric and cya-
nuric acid, not investigated in this study, may lead to
precipitation of melamine chemical-complex [21]. Ani-
mals studies further suggest that the combination of
melamine and cyanuric acid which is almost undissolva-
ble in water [8], appeared to be more toxic than each
substance alone [7, 19], and may therefore be a concern
for human consumption. Liu et al. [9] also suggest
that most proteins bind to melamine crystals [9]. The
proteins may be derived from the consequences of cell
injury, metabolic processes and binding functions [9].
These respective complexes may thus be contributory
factors in the earlier stage of possible renal/kidney ad-
verse condition or event occurring [13], which could
play an important role in stone formation [9]. Melamine
or melamine-complex accumulation may therefore occur
due to consumption of products that leads to ‘depot
formation’ in the kidney and other tissue. This may con-
tribute to the cause of renal/ kidney impairment ‘injury’
over time. This indicates that melamine contaminated
products (low levels) could contribute to adverse events,
even though the prescribed dosage is adhered to within
the TDI [4, 13]. The TDI value has seen a downward
trend over time [22], which is indicative of cautious con-
cern by international monitoring agencies, and may not
be a desired indicator of consumption safety based on
other factors and not on melamine only.
It follows that melamine contaminated nutritional sup-
plements (low levels) may be the contributory tipping
point for an adverse health event to occur. This could be
due the composition of the consumers overall diet, that
collectively may contain levels of melamine that allows
the TDI to be exceeded. Evidence of this although not abso-
lutely conclusive, (has also not been shown in humans), is
the significant presence of melamine residues (contamin-
ant) in milk from dairy cattle for at least 6 days after the
diet that contained the contaminant was removed [4].
Further, a study by Wu et al. [12], suggested that exposure
to low- dose melamine-related products may have the po-
tential to develop both uric acid and calcium urolithiasis in
adults and children [12, 14].
There is a need for actual dosage consumption studies
at extended and prescribed doses in both healthy and
chronic kidney disease subjects to measure the retention
capacity for melamine and /or melamine- complex in
these respective environments. It is also important to
Table 2 Nutritional Supplement formulation types investigated that tested ‘positive’ for Melamine contamination
Formulation
Types
Number of ‘positives’ for
Melamine (Samples acquired
in South Africa)
Overall
‘positives’ for
Melamine (%)
Produced and
purchased in South
Africa (n = 27)
Produced and
purchased in
South Africa (%)
Imported product
purchased in South
Africa n = 50
Imported product
purchased in South
Africa (%)
P 24 38 5 23 14 48
P/T 17 26 9 41 6 21
P/C 16 25 6 28 9 31
L/C 3 5 1 4 0 0
L 4 6 1 4 0 0
Total 64 100 17 100 29 100
Table 3 Tolerable Daily Intake (TDI) for Melamine
Organization TDI Maximum Dose Comment
WHO 0.2 mg/kg (2008) Co-occurrence of melamine with
cyanuric acid seems to be more
toxic. Cyanuric acid 1,5 mg/kg (TDI).50 kg person (10 mg)
Infant Formula -
1ppm
Foods - 2.5 ppm
EFSA 0.2 mg/kg (2010) In line with WHO (2008)
0.25 mg/kg (before
2010)
FDA 2.5 ppm (2008) “Acceptable” level – despite very
few studies on melamine and
human consumption
CAC Infant Formula –
1mg/kg
United Nations Food Standards
body
Food and animal
feed – 2.5 mg/kg
SA 2.5 ppm In line with WHO (2008)
World Health Organization (WHO), European Food Safety Authority (EFSA),
Food and Drug Administration, South Africa, Codex Alimentarius Commission
(CAC). http://en.wikipedia.org/wiki/Tolerable_daily_intake. (Accessed on the
10th December 2014)
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further investigate the risk associated with dietary co-
exposure, long-term exposure, and bacterial metabolism
of melamine, cyanuric and related triazines, and the sub-
sequent consequence of acute kidney injury, including
crystal formation [9, 11, 21], particularly if these chemical
moieties form part of nutritional supplement products.
Limitations of study
That analysis for melamine ‘only’ as done in this nutri-
tional supplement study is not adequate to show a pos-
sible product causal relationship for melamine crystal
formation. The presence of uric acid and/or cyanuric
acid, protein content, pesticide assessment (concentra-
tion) should be assessed in the same sample as they may
be the contributory compounds for precipitation of the
melamine-complex that may form the mechanism of
kidney failure/ nephrotoxicity, and/or urialisis.
Recommendations
Laboratory investigation needs to be done in nutritional
supplement products for; (i) uric acid (ii) cyanuric acid,
(iii) multiple protein assay systems to assess for adulteration
[5, 23], and (iv) assessment for pesticides (cyromazine)
[5, 21] that may convert to melamine, as by- or- end
products. These findings would contribute to a better un-
derstanding of the precipitation mechanism of the product-
complex, which would lead to accumulation in the kidney,
and compromise renal function integrity [14]. To enhance
the overall quality of supplements there needs to be an on-
going concerted effort to improve regulatory frameworks
[24, 25] and methods of surveillance and vigilance for un-
declared chemical compounds in nutritional supplement
products. Further, governments should have the responsi-
bility to equip appropriately, the law enforcement capabil-
ities, that will alert timeously via ‘early warning consumer
communication system’ of ‘problem products’. Also with
the necessary rigor have these products recalled, to avoid a
nutritional supplement scandal, as was the case with the
baby formula milk products in 2008. In the absence and
evaluation of controlled human clinical trials, and improv-
ing clinical diagnosis of adverse health effects, that may be
associated with consumption of dietary/nutritional, patients
and doctors’ reports, and case studies should be (re)
assessed. Supplements products should therefore be scien-
tifically tested, to ensure that side- (adverse) effects are not
inaccurately attributed and diagnosed, and that may further
lead to the establishment of incorrect policies, and/or warn-
ings of nutritional supplement products. To determine the
extent/and demography of kidney disease, and reflect on
the clinical records to determine possible association of the
kidney disease and burden of disease, due to melamine and
related chemical-complex formation.
Conclusion
The number of ‘positive’ tested products for melamine
in the overall cohort was 47 % (64), for South African
produced products 82 % (22), and, for imported prod-
ucts, bought in South Africa 58 % (58). The median con-
centration estimate for melamine in the products were,
6.0 μg/g for the overall cohort, 8.9 μg/g for South African
produced products, and 6.9 μg/g for imported products,
bought in South Africa (Tables 1, 2 and 3). Whilst the
concentration levels of melamine detected in the
Table 4 Global examples of Melamine contaminated levels
Product mg/kg Product mg/kg
Animal Feed 3.3 – 21,000 Liquid milk 8.6
Beverage (coffee/
orange juice
2 Contaminated Foods 0.38 – 945
Powdered milk
products
1 – 6.196 Processed Food
and Ingredients
0.6 – 6.694
Powdered
infant formula
0.1 – 2.563 Whole eggs 2.9 – 4.7
http://www.who.int/foodsafety/areas_work/chemical-risks/melamine/en/
(Accessed on the 10th December 2014)
Table 5 Illustrative examples of melamine contamination levels
and consumption relative to accepted TDI
Description High Medium Low
Concentration of Melamine (ng/g) 127030 6003 218
Formulation Type P/C P P
Indication of Protein/amino
acids content on Label (Y/N)
No Yes Yes
Product consumption quantity
per day based on consumed
and dose information (grams)
0.593 32 43
Indication of Melamine content
on label (Y/N)
No No No
Local/ International Product
purchase South Africa
Local International International
Dose information per tablet/
capsule (grams)
0.593 - -
Total Melamine consumption
per day (mg)
0.075 0.192 0.009
Table 6 Pre-determine product label information for the
Melamine ‘positives’ investigated
Information
category
Total number of
Melamine ‘positive’
products (n = 64)
Percentage of
total ‘positives’ (%)
Highest number
per information
category for a
given product
investigated
Dangers and
warnings
20 31 10
Scientific
indication
20 31 21
Disclaimers 19 30 4
Claims 21 33 12
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products is low overall (as contaminant), the number of
products containing the contaminant should place nutri-
tional supplement products under greater scrutiny. The
melamine (undeclared on product label) levels detected
in the nutritional supplements products investigated
were within the TDI limit guidelines of 0.2 mg/kg as
set by WHO and other organisations. So melamine
over-exposure should not be of concern to the consumer,
provided, the recommended guidelines of daily product
use, are adhered to. Further, the WHO TDI may not
be an appropriate guideline limit as it, (i) overlooks
the effect of chronic dosing, (ii) that consumption of
melamine contamination could come from different
nutritional supplement products sources, collectively or
consecutively, and (iii) that accumulation of low levels of
melamine as contaminant or in the presence of other
chemical- complex formation, over time, could lead to a
health hazard or incident.
Therefore, cautious monitoring intermittently, by
health safety authorities for melamine as contaminant
in nutritional supplement products would be adequate
at this juncture.
The findings further suggest research investigation
pertaining to melamine, in relation to actual dose con-
sumption as current findings were based on the assump-
tion that consumers would have adherence to the
prescribed label dosage information, rather than sub-
stantially exceeding this amount as may be the case. The
potential link of melamine (complex) to adverse health
consequences such as renal dysfunction will need to be
tested by assessing nutritional supplement products for
uric and cyanuric acid, pesticides, specifically cryoma-
zine, and assessing for melamine adulteration via mul-
tiple respective protein assays systems.
In conclusion, reforming the nutritional supplement
sector should continually consist of; (i) problem or po-
tential problem identification, (ii) benchmarking the way
towards greater consumption safety for the consumer,
(iii) refined, meaningful and implementable regulation,
and, (iv) adequate well trained officials, controls and
enforcement.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
GG contributed to the design, sample preparation, data collection, data
analyses, interpretation and presentation, the drafting and the main writing
to the paper. ML contributed to the design, data analyses, interpretation and
presentation and editing of paper. PS study design and editing of paper, LW
analysis of samples and data analyses facilitation, DH study design and
editing of paper. All authors read and approved the final manuscript.
Acknowledgements
The assistance of the Medical Research Council and the University of Cape
Town Research Committee is hereby acknowledged.
Author details
1Division of Clinical Pharmacology, Department of Medicine, University of
Cape Town, Faculty of Health Sciences, Observatory, Cape Town 7925, South
Africa. 2Division of Exercise Science and Sports Medicine, Department of
Human Biology, University of Cape Town, Cape Town, South Africa.
3Department of Medical BioSciences, University of the Western Cape, Cape
Town, South Africa.
Received: 3 February 2015 Accepted: 2 July 2015
References
1. Steinman HA, Jobson MR. Multiple organ failure – death of consumer
protection? S Afr Med J. 2010;100(8):494–7.
2. Nitish R, Dibyajyoti B, Rajasri B. Urinary Melamine: The proposed parameter
of melamine adulteration of food. Nutrition. 2014;30(4):380–5.
3. Cheng Y, Dong Y, Wu J, Yang X, Bai H, Zheng H, et al. Screening melamine
adulterant in milk powder with laser Raman spectrometry. J Food Compos
Anal. 2010;23:199–202.
4. Baynes RE, Barlow B, Mason SE, Riviere JE. Disposition of melamine residues
in blood and milk from dairy goats exposed to an oral bolus of melamine.
Food Chem Toxicol. 2010;48:2542–6.
5. Wu Y-N, Yun-Feng Z, Jin-Guang L, Malamine Analysis Group. A Survey on
Occurrence of Melamine and Its Analogues in Tainted Infant Formula in
China. Biomed Environ Sci. 2009;22:95–9.
6. Fu-Chen K, Yu-Ting T, Sing-Ru W, Ming-Tsang W, Yi-Ching L. Melamine activates
NFjB/COX-2/PGE2pathway and increases NADPH oxidase–dependent
ROS production in macrophages and human embryonic kidney cells.
Toxicol in Vitro. 2013;27:1603–11.
7. Chen Yng-Tay, Jiann Bang-Ping, Wu Chieh-Hao, Wu JhaolHuei, Chang
Shih-Chieh, Chien Maw-Sheng, Hsuan Shih-Ling, Lin Yi-Lo, Chen TerHsin,
Tsai Fuu-Jen, Liao Jiunn-Wang. Kidney Stone Distribution Caused by
Melamine and Cyanuric Acid in Rats: Clinica Chimica Acta, 2014,10.1016/j.
cca.2014.01.003
8. Ching Yan C, Kai On C, Chung Shun H, Sung Shing K, Ho Ming C, Kwok Pui
F, et al. Melamine in prenatal and postnatal organs in rats. Reprod Toxicol.
2013;35:40–7.
9. Liu J-d, Liu J-j, Yuan J-h, Tao G-h, Wub D-s, Yang X-f, et al. Proteome of
melamine urinary bladder stones and implication for stone Formation.
Toxicol Lett. 2012;212:307–14.
10. Baynes RE, Smith G, Mason SE, Barrett E, Barlow BM, Riviere JE.
Pharmacokinetics of melamine in pigs following intravenous administration.
Food Chem Toxicol. 2008;46:1196–200.
11. Qin Y, Lv X, Li J, Qi G, Diao Q, Liu G, et al. Assessment of melamine
contamination in crop, soil and water in China and risks of melamine
accumulation in animal tissues and products. Environ Int. 2010;36:446–52.
12. Chia-Fang W, Chia-Chu L, Bai-Hsiun C, Shu-Pin H, Hei-Hwa L, Yii-Her C,
et al. Urinary melamine and adult urolithiasis in Taiwan. Clin Chim Acta.
2010;411:184–9.
13. Ching-Wan L, Lawrence L, Xiaoyan C, Sidney T, Samson Sai-Yin W, Yue C,
et al. Diagnosis and spectrum of melamine-related renal disease: Plausible
mechanism of stone formation in humans. Clin Chim Acta. 2009;402:150–5.
14. Lin Y-T, Tsai M-T, Chen Y-L, Cheng C-M, Hung C-C, Chia- Fang W, et al. Can
melamine levels in 1-spot overnight urine specimens predict the total
previous 24-hour melamine excretion level in school children? Clin Chim
Acta. 2013;420:128–33.
15. María I, Sancho JV, Félix H. Determination of melamine in milk- based products
and other food and beverage products by ion-pair liquid chromatography–
tandem mass spectrometry. Anal Chim Acta. 2009;649:91–7.
16. Gossner, C., Schlundt,J., Embarek, P., Hird, S., Lo-Fo-Wong, D., Beltran, J.,
Teoh, K., Tritscher, A. The Melamine incident: Implications for International
Food and Feed Safety, 2009, 117: (12):1803–1808
17. Venter K, van der Merwe D, de Beer H, Kempen E, Bosman M. Consumers’
perceptions of food packaging: an exploratory investigation in
Potchefstroom, South Africa. Int J Consumer Studies. 2011;35:273–81.
18. Meltzer S, Kohler R, Jakoet I, Noakes T. A practical guide to the use of
nutritional supplements in South Africa. CME. 2004;22(3):142–4.
19. Hua Y, Zhu J-f, Rui-ing S, Ling-ling C, Rui-Han S, Ye D, et al. Induction of
Apoptosis in the Immature Mouse Testes by a Mixture of Melamine and
Cyanuric Acid. J Integrative Agriculture. 2012;11(12):2058–66.
Gabriels et al. Nutrition Journal  (2015) 14:69 Page 6 of 7
20. Liu G, Li S, Jia J, Yu C, He J, Yu C, et al. Pharmacokinetic study of melamine
in rhesus monkey after a single oral administration of a tolerable daily
intake dose. Regul Toxicol Pharmacol. 2010;56:193–6.
21. Sprando RL, Renate R, Stine CB, Thomas B, Nicholas O, Michael S, et al.
Timing and route of exposure affects crystal formation in melamine and
cyanuric exposed male and female rats: Gavage vs. feeding. Food Chem
Toxicol. 2012;50:4389–97.
22. Hsieh DPH, Chiang CF, Chiang PH, Wen CP. Toxicological analysis points to
a lower tolerable daily intake of melamine in food. Regul Toxicol Pharmacol.
2009;55:13–6.
23. Anjalie F, Jeffrey F. Melamine and cyanuric acid do not interfere with
Bradford and Ninhydrin assays for protein determination. Food Chem.
2010;121:912–7.
24. Xiaofang P, Annuradha T, Anton A, Liana G, Wei H, Ruijia Y. The China
melamine milk scandal and its implications for food safety regulation.
Food Policy. 2011;36:412–20.
25. Gabriels G, Lambert M, Smith P. Information on labels of nutritional
supplements, time for legislation? South African J Clinical Nutrition. 2012;25
(1):22–4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Gabriels et al. Nutrition Journal  (2015) 14:69 Page 7 of 7
